个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共18条记录  
  • Evaluation of Diarylureas for Activity Against Plasmodium falciparum
    [作者:ZHANG YIQUN; ANDERSON MARC; WEISMAN JENNIFER L; LU MIN; CHOY CINDY J; BOYD VINCENT A; PRICE JEANINE; SIGAL MARTINA; CLARK JULIE; CONNELLY MICHELE; ZHU FANGYI; GUIGUEMDE W ARMAND; JEFFRIES CYNTHIA; YANG LEI; LEMOFF ANDREW; LIOU ALLY P; WEBB THOMAS R; DERISI JOSEPH L; GUY R KIPLIN,期刊:ACS Medicinal Chemistry Letters, 页码:460-465 , 文章类型: Article,,卷期:2010年1-9]
  • A library of diarylurea insulin-like growth factor 1 receptor inhibitors was screened for activity against chloroquine-sensitive (3D7) and chloroquine-resistant (K1) strains of Plasmodium falciparum. The 4-aminoquinaldin...
  • Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase
    [作者:CHENG CLIFF C; HUANG XIAOHUA; SHIPPS GERALD W JR; WANG YUSEN; WYSS DANIEL F; SOUCY KYLE A; JIANG CHUANKUI; AGRAWAL SONY; FERRARI ERIC; HE ZHIQING; HUANG HC,期刊:ACS Medicinal Chemistry Letters, 页码:466-471 , 文章类型: Article,,卷期:2010年1-9]
  • Pyridine carboxamide-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase were diversified and optimized to a variety of topologically related scaffolds. In particular, the 2-methyl nicotinic acid scaffold was...
  • Discovery of Omecamtiv Mecarbil the First, Selective, Small Molecule Activator of Cardiac Myosin
    [作者:MORGAN BRADLEY P; MUCI ALEXANDER; LU PUPING; QIAN XIANGPING; TOCHIMOTO TODD; SMITH WHITNEY W; GARARD MARC; KRAYNACK ERICA; COLLIBEE SCOTT; SUEHIRO ION; TOMASI ADAM; VALDEZ S COREY; WANG WENYUE; JIANG HONG; HARTMAN JAMES; RODRIGUEZ HECTOR M; KAWAS RAJA; SYLVESTER SHEILA; ELIAS KATHLEEN A; GODINEZ GUILLERMO; LEE KENNETH; ANDERSON ROBERT; SUEOKA SANDRA; XU DONGHONG; WANG ZHENGPING; DJORDJEVIC NEBOJSA; MALIK FADY I; MORGANS DAVID J JR,期刊:ACS Medicinal Chemistry Letters, 页码:472-477 , 文章类型: Article,,卷期:2010年1-9]
  • We report the design, synthesis, and optimization of the first, selective activators of cardiac myosin. Starting with a poorly soluble, nitroaromatic hit compound (1), potent, selective, and soluble myosin activators wer...
  • A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
    [作者:GOMEZGALENO JORGE E; DANG QUN; NGUYEN THANH H; BOYER SERGE H; GROTE MATTHEW P; SUN ZHILI; CHEN MINGWEI; CRAIGO WILLIAM A; VAN POELJE PAUL D; MACKENNA DEIDRE A; CABLE EDWARD E; ROLZIN PAUL A; FINN PATRICIA D; CHI BERT; LINEMEYER DAVID L; HECKER SCOTT J; ERION MARK D,期刊:ACS Medicinal Chemistry Letters, 页码:478-482 , 文章类型: Article,,卷期:2010年1-9]
  • AMP-activated protein kinase (AMPK) is a heterotrimeric kinase that regulates cellular. energy metabolism by affecting energy-consuming pathways such as de novo. lipid biosynthesis and glucose production as well as energ...
  • Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity
    [作者:XUE CHUBIAO; CHEN LIHUA; CAO GANFENG; ZHANG KE; WANG ANLAI; MELONI DAVID; GLENN JOSEPH; ANAND RAJAN; XIA MICHAEL; KONG LING; HUANG TAISHENG; FENG HAO; ZHENG CHANGSHENG; LI MEI; GALYA LAURINE; ZHOU JIACHENG; SHIN NIU; BARIBAUD FREDRIC; SOLOMON KIM; SCHERLE PEGGY; ZHAO BITAO; DIAMOND SHARON; EMM TOM; KELLER DOUGLAS; CONTEL NANCY; YELESWARAM SWAMY; VADDI KRIS; HOLLIS GREGORY; NEWTON ROBERT; FRIEDMAN STEVEN; METCALF BRIAN,期刊:ACS Medicinal Chemistry Letters, 页码:483-487 , 文章类型: Article,,卷期:2010年1-9]
  • To identify a CCR5 antagonist as an HIV-1 entry inhibitor, we designed a novel series of indane derivatives based on conformational considerations. Modification on the indane ring led to the discovery of compound 22a (IN...
  • Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy
    [作者:CHEKLER EUGENE L PIATNITSKI; KISELYOV ALEXANDER S; OUYANG XIAOHU; CHEN XIAOLING; PATTAROPONG VATEE; WANG YING; TUMA M CAROLINA; DOODY JACQUELINE F,期刊:ACS Medicinal Chemistry Letters, 页码:488-492 , 文章类型: Article,,卷期:2010年1-9]
  • In an effort to develop potent, orally bioavailable compounds for the treatment of neoplastic diseases, we developed a class of dual VEGFR-2 kinase and tubulin inhibitors. Targeting the VEGFR receptor kinase and tubulin ...
  • Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity
    [作者:OTT GREGORY R; TRIPATHY RABINDRANATH; CHENG MANGENG; MCHUGH ROBERT; ANZALONE ANDREW V; UNDERINER TED L; CURRY MATTHEW A; QUAIL MATTHEW R; LU LIHUI; WAN WEIHUA; ANGELES THELMA S; ALBOM MARK S; AIMONE LISA D; ATOR MARK A; RUGGERI BRUCE A; DORSEY BRUCE D,期刊:ACS Medicinal Chemistry Letters, 页码:493-498 , 文章类型: Article,,卷期:2010年1-9]
  • A series of novel 7-amino-1,3,4,5-tetrahydrobenzo[b]azepin-2-one derivatives within the diaminopyrimidine class of kinase inhibitors were identified that target anaplastic lymphoma kinase (ALK). These inhibitors are pote...
  • Short-Acting T-Type Calcium Channel Antagonists Significantly Modify Sleep Architecture in Rodents
    [作者:YANG ZHIQIANG; SCHLEGEL KELLYANN S; SHU YOUHENG; REGER THOMAS S; CUBE ROWENA; MATTERN CHRISTA; COLEMAN PAUL J; SMALL JIM; HARTMAN GEORGE D; BALLARD JEANINE; TANG CUYUE; KUO YUHSIN; PRUEKSARITANONT THOMAYANT; NUSS CINDY E; DORAN SCOTT; FOX STEVE V; GARSON SUSAN L; LI YUXING; KRAUS RICHARD L; UEBELE VICTOR N; TAYLOR ADEKEMI B; ZENG WEI; FANG WEI; CHAVEZENG CYNTHIA; TROYER MATTHEW D; LUK JULIE ANN; LAETHEM TINE; COOK WILLIAM O; RENGER JOHN J; BARROW JAMES C,期刊:ACS Medicinal Chemistry Letters, 页码:504-509 , 文章类型: Article,,卷期:2010年1-9]
  • A novel phenyl acetamide series of short-acting T-type calcium channel antagonists has been identified and evaluated using in vitro and in vivo assays. Heterocycle substitutions of the 4-position of the phenyl acetamides...
  • Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR
    [作者:JIN MEIZHONG; GOKHALE PRAFULLA C; COOKE ANDY; FOREMAN KENNETH; BUCK ELIZABETH; MAY EARL W; FENG LIXIN; BITTNER MARK A; KADALBAJOO MRIDULA; LANDFAIR DARLA; SIU KAM W; STOLZ KATHRYN M; WERNER DOUGLAS S; LAUFER RADOSLAW S; LI ANHU; DONG HANQING; STEINIG ARNO G; KLEINBERG ANDREW; YAO YAN; PACHTER JONATHAN A; WILD ROBERT; MULVIHILL MARK J,期刊:ACS Medicinal Chemistry Letters, 页码:510-515 , 文章类型: Article,,卷期:2010年1-9]
  • This report describes the investigation of a series of 5,7-disubstituted imidazo[5,1-f][1,2,4]triazine inhibitors of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR). Structure-activity relationsh...
  • Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues
    [作者:ROSEN MARK D; VENKATESAN HARIHARAN; PELTIER HILLARY M; BEMBENEK SCOTT D; KANELAKIS KIMON C; ZHAO LUCY X; LEONARD BARRY E; HOCUTT FRANCES M; WU XIAODONG; PALOMINO HEATHER L; BRONDSTETTER THERESA I; HAUGH PETER V; CAGNON LAURENCE; YAN WEN; LIOTTA LISA A; YOUNG ANDREW; MIRZADEGAN TARA; SHANKLEY NIGEL P; BARRETT TERRANCE D; RABINOWITZ MICHAEL H,期刊:ACS Medicinal Chemistry Letters, 页码:526-529 , 文章类型: Article,,卷期:2010年1-9]
  • HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiological responses to hypoxia by modulating the levels of hypoxia inducible factor 1-alpha (HIF1 alpha). Certain benzimidazole-2-pyrazole carb...